Ateş, Ö. Et Al. 2015. Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer. ASCO Annual Meeting .

Ateş, Ö., Babacan, T., SARICI, F., KERTMEN, N., CENOLİ, A., Akın, S., ... KARAKAS, Y.(2015). Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer . ASCO Annual Meeting

Ateş, ÖZTÜRK Et Al. "Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer," ASCO Annual Meeting, 2015

Ateş, ÖZTÜRK Et Al. "Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer." ASCO Annual Meeting , 2015

Ateş, Ö. Et Al. (2015) . "Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer." ASCO Annual Meeting .

@conferencepaper{conferencepaper, author={ÖZTÜRK ATEŞ Et Al. }, title={Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer}, congress name={ASCO Annual Meeting}, city={}, country={}, year={2015}}